找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Current Advances in Osteosarcoma; Eugenie S. Kleinerman, M.D. Book 20141st edition Springer Nature Switzerland AG 2014 bone cancer.cancer.

[复制链接]
查看: 30562|回复: 59
发表于 2025-3-21 19:35:30 | 显示全部楼层 |阅读模式
书目名称Current Advances in Osteosarcoma
编辑Eugenie S. Kleinerman, M.D.
视频video
概述The topics provide a starting block for unified discussions for osteosarcoma researchers in order to move the field forward.The volume editor is an internationally recognized leader in the field of sa
丛书名称Advances in Experimental Medicine and Biology
图书封面Titlebook: Current Advances in Osteosarcoma;  Eugenie S. Kleinerman, M.D. Book 20141st edition Springer Nature Switzerland AG 2014 bone cancer.cancer.
描述.Current Advances in Osteosarcoma edited by Dr. Eugenie S. Kleinerman summarizes molecular and genetic characteristics, new therapeutic ideas, and biological characteristics that have been uncovered in the past 10 years. Osteosarcoma is an aggressive malignant neoplasm and it is also the most common histological form of bone cancer. It accounts for approximately 56% of new bone tumors, making it the most primary malignant bone tumor in children and adolescents. The lungs are the most common site of metastases and once osteosarcoma spreads to the lungs, it is very difficult to treat. To improve the outcome of this disease, the biology of osteosarcoma needs to be better understood. There are numerous investigators around the world who have made seminal discoveries about the important molecular pathways and genetic alterations that contribute to the development and metastases of osteosarcoma. Other investigators have proposed novel therapeutic strategies including some based on the molecular and genetic phenotype of the disease. Current Advances in Osteosarcoma summarizes all of these new discoveries in one singular text, which will help move the field forward..
出版日期Book 20141st edition
关键词bone cancer; cancer; metastasis; osteosarcoma; pediatric cancer
版次1
doihttps://doi.org/10.1007/978-3-319-04843-7
isbn_softcover978-3-319-34459-1
isbn_ebook978-3-319-04843-7Series ISSN 0065-2598 Series E-ISSN 2214-8019
issn_series 0065-2598
copyrightSpringer Nature Switzerland AG 2014
The information of publication is updating

书目名称Current Advances in Osteosarcoma影响因子(影响力)




书目名称Current Advances in Osteosarcoma影响因子(影响力)学科排名




书目名称Current Advances in Osteosarcoma网络公开度




书目名称Current Advances in Osteosarcoma网络公开度学科排名




书目名称Current Advances in Osteosarcoma被引频次




书目名称Current Advances in Osteosarcoma被引频次学科排名




书目名称Current Advances in Osteosarcoma年度引用




书目名称Current Advances in Osteosarcoma年度引用学科排名




书目名称Current Advances in Osteosarcoma读者反馈




书目名称Current Advances in Osteosarcoma读者反馈学科排名




单选投票, 共有 1 人参与投票
 

0票 0.00%

Perfect with Aesthetics

 

1票 100.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 22:19:11 | 显示全部楼层
Wnt Signaling in Osteosarcomaonal co-activator β-catenin, which ultimately controls key developmental gene expressions. Given the central role of this mediator, inhibition of Wnt/β-catenin signaling has been investigated as a potential strategy for cancer control. In OS, several secreted protein families modulate the Wnt/β-cate
发表于 2025-3-22 01:45:05 | 显示全部楼层
Receptor Tyrosine Kinases in Osteosarcoma: Not Just the Usual Suspectse then validated using independent validation experiments. From these results, we identified four RTKs (Axl, EphB2, FGFR2, and Ret) that have not been previously studied in osteosarcoma and provide targets for the development of novel therapeutics.
发表于 2025-3-22 05:56:12 | 显示全部楼层
发表于 2025-3-22 09:47:21 | 显示全部楼层
Developmental Pathways Hijacked by OsteosarcomaThis pathway also helps regulate expression of the mature osteoblast protein osteocalcin. YAP also regulates expression of MT1-MMP, a membrane-bound matrix metalloprotease responsible for remodeling the extracellular matrix surrounding the osteoblasts. YAP, in turn, can be regulated by the ERBB fami
发表于 2025-3-22 15:22:25 | 显示全部楼层
发表于 2025-3-22 19:00:15 | 显示全部楼层
Role of Ezrin in Osteosarcoma Metastasis protein that associated with OS and other cancers. Ezrin is the prototypical ERM (Ezrin/Radixin/Moesin) protein family member. ERMs function as linker proteins connecting the actin cytoskeleton and the plasma membrane. Since our initial identification of ezrin in pediatric sarcoma, an increasing un
发表于 2025-3-22 22:31:55 | 显示全部楼层
发表于 2025-3-23 02:14:15 | 显示全部楼层
发表于 2025-3-23 08:48:30 | 显示全部楼层
Using Canine Osteosarcoma as a Model to Assess Efficacy of Novel Therapies: Can Old Dogs Teach Us Nethout chemotherapy that could not be done in humans with osteosarcoma due to ethical concerns. This chapter will focus on the novel therapies in the dog that have been reported or are in veterinary clinical trials at the author’s institution. It is hoped that collaboration between veterinary oncolog
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-1 17:20
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表